secwatch.observer — SEC 8-K summary
======================================

Issuer:     GERON CORP (GERN)
CIK:        0000886744
Form:       8-K
Filed at:   2023-11-28T23:59:59+00:00
Accession:  0000950170-23-066396
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Geron appoints Gaurav Aggarwal, M.D. to its Board of Directors
--------------------------------------------------------------

- Dr. Aggarwal appointed as Class III director effective Nov. 26, 2023; term expires at 2026 annual meeting.
- Board determined Aggarwal independent under Nasdaq rules; he brings 20+ years life sciences investing experience.
- Received initial option for 200,000 shares at $1.97/share, vesting in three equal annual installments.
- Eligible for annual cash retainer of $42,500 and annual option grants of 125,000 shares starting in 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/886744/000095017023066396/0000950170-23-066396-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/886744/000095017023066396/gern-20231126.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-066396

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer